American researchers have identified the specific mechanism by which stigmatization of people living with HIV leads to loss of viral suppression. Stimulant and tobacco use as a form of coping behavior plays a central role in this chain. The study is the first to link discrimination to a biomedical outcome — viral load — through concrete behavioral pathways.
The study was conducted using baseline data from the American Remote Contact HIV Epidemiology Study (ARCHES), a national cohort of 1,000 sexually minoritized men living with HIV recruited between November 2023 and October 2024 through geosocial networking apps and existing HIV research databases. A documented history of antiretroviral therapy (ART) adherence challenges was a required condition for participation. The mean age of participants was 43 years. By racial composition: 45% identified as White, 39.8% as Black, and 20.9% as Hispanic or Latino. At enrollment, 86% of participants had achieved viral suppression, defined as HIV RNA below 200 copies/mL based on laboratory results or recent provider records.
Moderate to severe substance use was common among participants: 55.5% met criteria for stimulant use, 43% for cannabis, 38.8% for tobacco, and 20% for alcohol. Clinically meaningful depression, measured by a PHQ-8 score of 10 or higher, was identified in 33.7% of participants.
The analysis was grounded in the HIV-related Stigma, Engagement in Care, and Health Outcomes Framework. Researchers applied path analysis — a form of structural equation modeling — to examine both direct and indirect associations between intersectional discrimination and viral suppression.
The central finding was that the relationship between discrimination and loss of viral control operates not directly, but through behavioral mechanisms. Higher discrimination scores were associated with greater stimulant use severity (β = 0.25) and greater tobacco use (β = 0.22). In turn, stimulant use predicted lower odds of viral suppression (β = –0.10), and tobacco use did so even more strongly (β = –0.14). Depression and perceived stress, while statistically associated with discrimination, did not emerge as significant mediators on the pathway to viral nonsuppression in the final model. Greater social support, by contrast, was independently associated with better viral control outcomes.
The authors describe the identified phenomenon as an “indirect-only mediation effect”: discrimination does not raise viral load directly, but rather shapes behavioral patterns — including substance use as a stress-coping mechanism — which then directly affect the ability to maintain viral suppression. This distinction is critically important, as it demonstrates that social inequity translates into biological consequences through layered behavioral, structural, and psychosocial factors, rather than through a single linear cause-and-effect relationship.
From a clinical standpoint, the study makes the case for integrated HIV care models that incorporate routine mental health screening, substance use support embedded within HIV services, trauma-informed approaches to patient communication, culturally responsive care, and greater attention to social support systems. The researchers emphasize that the point is not to individualize blame for coping behaviors, but to address a systemic question — what conditions give rise to these behaviors, and how can health systems respond more effectively.
The article “Associations Between Intersectional Discrimination and HIV Viral Suppression: Examining Indirect Pathways Through Mental Health, Substance Use, Stress, and Social Support among Sexual Minoritized Men Living with HIV” was published on April 17, 2026, in the Journal of Acquired Immune Deficiency Syndrome (JAIDS). The lead author is Renessa Williams, Ph.D., RN, Assistant Professor at the School of Nursing and Health Sciences, University of Miami.